Pitchfile.Updated 16 Nov 2026
Horizon Europe · Cascade grant

EP PerMed: Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)

This call funds research projects that develop and test new cell and gene therapies for personalised medicine in human health. Each project must use at least one of four approaches: somatic cell therapy, gene therapy, combined cell and gene therapy, or novel biological products. The description does not state a grant amount or who is eligible, so check the full call text before applying.
Official call text
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM. At least one of the following approaches must be employed: Somatic cell therapeutics; Gene therapeutics; Combined cell- and gene therapeutics; Novel biological products. For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.

New tenders and grants in your inbox every Monday

One email a week with every new tender and grant, sorted by deadline. Free.